RUNX3 Has an Oncogenic Role in Head and Neck Cancer
Takaaki Tsunematsu, Yasusei Kudo, Shinji Iizuka et al. · 2009
Read RUNX3 Has an Oncogenic Role in Head and Neck Cancer by Takaaki Tsunematsu, Yasusei Kudo, Shinji Iizuka et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005892.txt.
Description
Takaaki Tsunematsu and co-authors reported in 2009 a surprise: a supposed tumor suppressor acts as an oncogene in head and neck cancer. RUNX3 normally helps a growth-control pathway suppress tumors, and its loss aids several cancers. Yet in head and neck tumors its levels ran high.
The team found RUNX3 actually promotes growth in this cancer type. Context flips the protein's role, a caution against one-size labels in cancer genes. Treatment ideas based on restoring RUNX3 could backfire here. The study argues for testing each gene's role cancer by cancer.
Catalog record
| CREATOR | Takaaki Tsunematsu, Yasusei Kudo, Shinji Iizuka et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005892